Company Name: Tetraphase Pharmaceuticals, Inc.   

Tetraphase Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. The company is engaged in the development of antibiotics for multidrug-resistant (MDR) infections. The company’s lead product candidate is a broad-spectrum intravenous and oral antibiotic designed to treat multidrug-resistant infections (including MDR Gram-negative infections).

Ticker Symbol: TTPH (NASDAQ)

Company Website: http://tphase.com

Social Media:

Tetraphase Pharmaceuticals LinkedIn Page

Tetraphase Pharmaceuticals Twitter

Headquarters: Watertown, MA